Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 16 results.
User Information
Export Records
  1. 1.   Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia
  2. Liu, X.; Ryl, L.; Yang, J.; Liao, A. J.; Aliaga, C.; Watts, R.; Tan, S. F.; Kaiser, J.; Shanmugavelandy, S. S.; Rogers, A.; Loughran, K.; Petersen, B.; Yuen, J.; Meng, F. X.; Baab, K. T.; Jarbadan, N. R.; Broeg, K.; Zhang, R. R.; Liao, J. S.; Sayers, T. J.; Kester, M.; Loughran, T. P.
  3. Blood. 2010, Nov; 116(20): 4192-4201.
  1. 2.   Antigen Presented by Tumors In vivo Determines the Nature of CD8(+) T-Cell Cytotoxicity
  2. Shanker, A.; Brooks, A. D.; Jacobsen, K. M.; Wine, J. W.; Wiltrout, R. H.; Yagita, H.; Sayers, T. J.
  3. Cancer Research. 2009 69(16): 6615-6623.
  1. 3.   Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation
  2. Sun, K.; Li, M. H.; Sayers, T. J.; Welniak, L. A.; Murphy, W. J.
  3. Blood. 2008 112(4): 1522-1529.
  1. 4.   The CD95 receptor: Apoptosis revisited
  2. Peter, M. E.; Budd, R. C.; Desbarats, J.; Hedrick, S. M.; Hueber, A. O.; Newell, M. K.; Owen, L. B.; Tschopp, J.; Wajant, H.; Wallach, D.; Wiltrout, R. H.; Zornig, M.; Lynch, D. H.
  3. Cell. 2007, May; 129(3): 447-450.
  1. 5.   The proinflammatory cytokine interleukin-18 alters multiple signaling pathways to inhibit natural killer cell death
  2. Hodge, D. L.; Subleski, J. J.; Reynolds, D. A.; Buschman, M. D.; Schill, W. B.; Burkett, M. W.; Malyguine, A. M.; Young, H. A.
  3. Journal of Interferon and Cytokine Research. 2006, Oct; 26(10): 706-718.
  1. 6.   NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function
  2. Abdool, K.; Cretney, E.; Brooks, A. D.; Kelly, J. M.; Swann, J.; Shanker, A.; Bere, E. W.; Yokoyama, W. M.; Ortaldo, J. R.; Smyth, M. J.; Sayers, T. J.
  3. Journal of Immunology. 2006, Aug; 177(4): 2575-2583.
  1. 7.   Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms
  2. Grivennikov, S. I.; Kuprash, D. V.; Liu, Z. G.; Nedospasov, S. A.
  3. International Review of Cytology - a Survey of Cell Biology, Vol 252. 2006; 252 : 129-+.
  1. 8.   Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy
  2. Sayers, T. J.; Murphy, W. J.
  3. Cancer Immunology Immunotherapy. 2006, JAN; 55(1): 76-84.
  1. 9.   NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer
  2. Smyth, M. J.; Swann, J.; Kelly, J. M.; Cretney, E.; Yokoyama, W. M.; Diefenbach, A.; Sayers, T. J.; Hayakawa, Y.
  3. Journal of Experimental Medicine. 2004, NOV 15; 200(10): 1325-1335.
  1. 10.   Activating mutations in STAT3 and STAT5 differentially affect cellular proliferation and apoptotic resistance in multiple myeloma cells
  2. Hodge, D. R.; Xiao, W. H.; Wang, L. H.; Li, D. P.; Farrar, W. L.
  3. Cancer Biology & Therapy. 2004 3(2): 188-194.
  1. 11.   Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils
  2. Kamohara, H.; Matsuyama, W.; Shimozato, O.; Abe, K.; Galligan, C.; Hashimoto, S. I.; Matsushima, K.; Yoshimura, T.
  3. Immunology. 2004 111(2): 186-194.
  1. 12.   NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade
  2. Koh, C. Y.; Ortaldo, J. R.; Blazar, B. R.; Bennett, M.; Murphy, W. J.
  3. Blood. 2003 102(12): 4067-4075.
  1. 13.   Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice
  2. Moayeri, M.; Haines, D.; Young, H. A.; Leppla, S. H.
  3. Journal of Clinical Investigation. 2003 112(5): 670-682.
  1. 14.   Nickel(II)-induced apoptosis in murine T cell hybridoma cells is associated with increased Fas ligand expression
  2. Kim, K.; Lee, S. H.; Seo, Y. R.; Perkins, S. N.; Kasprzak, K. S.
  3. Toxicology and Applied Pharmacology. 2002 185(1): 41-47.
  1. 15.   IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy
  2. Wigginton, J. M.; Gruys, E.; Geiselhart, L.; Subleski, J.; Komschlies, K. L.; Park, J. W.; Wiltrout, T. A.; Nagashima, K.; Back, T. C.; Wiltrout, R. H.
  3. Journal of Clinical Investigation. 2001 108(1): 51-62.
  1. 16.   T cell lysis of murine renal cancer: multiple signaling pathways for cell death via Fas
  2. Sayers, T. J.; Brooks, A. D.; Seki, N.; Smyth, M. J.; Yagita, H.; Blazar, B. R.; Malyguine, A. M.
  3. Journal of Leukocyte Biology. 2000 68(1): 81-86.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel